Helmholtz Munich
@helmholtzmunich.bsky.social
The official Bluesky account of the German Research Center for Environmental Health
We discover breakthrough solutions for better health in a changing world!
Website: https://www.helmholtz-munich.de/
We discover breakthrough solutions for better health in a changing world!
Website: https://www.helmholtz-munich.de/
🌍 The #HelmholtzMunich Talent Forum 2025 brought together exceptional early-career scientists in #epigenetics & nucleic acids research to foster exchange, collaboration & research excellence. 👩🔬👨🔬
👉 t1p.de/3dsix
@boyanbonev.bsky.social @epihmgu.bsky.social
#TalentForum
👉 t1p.de/3dsix
@boyanbonev.bsky.social @epihmgu.bsky.social
#TalentForum
November 25, 2025 at 12:56 PM
🌍 The #HelmholtzMunich Talent Forum 2025 brought together exceptional early-career scientists in #epigenetics & nucleic acids research to foster exchange, collaboration & research excellence. 👩🔬👨🔬
👉 t1p.de/3dsix
@boyanbonev.bsky.social @epihmgu.bsky.social
#TalentForum
👉 t1p.de/3dsix
@boyanbonev.bsky.social @epihmgu.bsky.social
#TalentForum
🥇 Dr. Eric Wenzel (HI-MAG, #HelmholtzMunich, Leipzig University & Medical Faculty of Leipzig University) receives the 2025 Jürgen-Bierich Research Award for uncovering a novel genetic cause of severe early-onset #obesity and advancing targeted treatments.
👉 t1p.de/7bhvt
@unileipzig.bsky.social
👉 t1p.de/7bhvt
@unileipzig.bsky.social
November 24, 2025 at 1:51 PM
🥇 Dr. Eric Wenzel (HI-MAG, #HelmholtzMunich, Leipzig University & Medical Faculty of Leipzig University) receives the 2025 Jürgen-Bierich Research Award for uncovering a novel genetic cause of severe early-onset #obesity and advancing targeted treatments.
👉 t1p.de/7bhvt
@unileipzig.bsky.social
👉 t1p.de/7bhvt
@unileipzig.bsky.social
#HelmholtzMunich to Advance AI Benchmarking With Three Newly Funded Projects
Shaping the next generation of trustworthy, scientifically robust #AI across research domains.
👉 t1p.de/ubzam
@helmholtz.de @helmholtzai.bsky.social @comphealthmunich.bsky.social @helmholtzimaging.bsky.social @stes.io
Shaping the next generation of trustworthy, scientifically robust #AI across research domains.
👉 t1p.de/ubzam
@helmholtz.de @helmholtzai.bsky.social @comphealthmunich.bsky.social @helmholtzimaging.bsky.social @stes.io
November 21, 2025 at 8:26 AM
#HelmholtzMunich to Advance AI Benchmarking With Three Newly Funded Projects
Shaping the next generation of trustworthy, scientifically robust #AI across research domains.
👉 t1p.de/ubzam
@helmholtz.de @helmholtzai.bsky.social @comphealthmunich.bsky.social @helmholtzimaging.bsky.social @stes.io
Shaping the next generation of trustworthy, scientifically robust #AI across research domains.
👉 t1p.de/ubzam
@helmholtz.de @helmholtzai.bsky.social @comphealthmunich.bsky.social @helmholtzimaging.bsky.social @stes.io
🫁 How can Chronic Obstructive Pulmonary Disease (COPD) be prevented and effectively treated?
Over 120 clinicians, researchers, and patient advocates met at the ERS–COPD-iNET Research Symposium in Prague to discuss innovative approaches.
👉 t1p.de/kwjrt
#COPD
Over 120 clinicians, researchers, and patient advocates met at the ERS–COPD-iNET Research Symposium in Prague to discuss innovative approaches.
👉 t1p.de/kwjrt
#COPD
November 19, 2025 at 11:41 AM
🫁 How can Chronic Obstructive Pulmonary Disease (COPD) be prevented and effectively treated?
Over 120 clinicians, researchers, and patient advocates met at the ERS–COPD-iNET Research Symposium in Prague to discuss innovative approaches.
👉 t1p.de/kwjrt
#COPD
Over 120 clinicians, researchers, and patient advocates met at the ERS–COPD-iNET Research Symposium in Prague to discuss innovative approaches.
👉 t1p.de/kwjrt
#COPD
#WorldCOPDDay
“Short of Breath, Think COPD”
🫁#HelmholtzMunich Drives Research for New Diagnostics, Therapies and Prevention Strategies
👉 t1p.de/2sxmc
@onderyildirimcpc.bsky.social @lmu-klinikum.bsky.social
@dzg-forschen.bsky.social
#COPDAwareness, #LungHealth #ThinkCOPD #COPDDay
“Short of Breath, Think COPD”
🫁#HelmholtzMunich Drives Research for New Diagnostics, Therapies and Prevention Strategies
👉 t1p.de/2sxmc
@onderyildirimcpc.bsky.social @lmu-klinikum.bsky.social
@dzg-forschen.bsky.social
#COPDAwareness, #LungHealth #ThinkCOPD #COPDDay
November 19, 2025 at 9:47 AM
#WorldCOPDDay
“Short of Breath, Think COPD”
🫁#HelmholtzMunich Drives Research for New Diagnostics, Therapies and Prevention Strategies
👉 t1p.de/2sxmc
@onderyildirimcpc.bsky.social @lmu-klinikum.bsky.social
@dzg-forschen.bsky.social
#COPDAwareness, #LungHealth #ThinkCOPD #COPDDay
“Short of Breath, Think COPD”
🫁#HelmholtzMunich Drives Research for New Diagnostics, Therapies and Prevention Strategies
👉 t1p.de/2sxmc
@onderyildirimcpc.bsky.social @lmu-klinikum.bsky.social
@dzg-forschen.bsky.social
#COPDAwareness, #LungHealth #ThinkCOPD #COPDDay
Fine-Tuning #Immunity: The Role of #Ubiquitination in T cell Activation 🔬
A new study by researchers at #HelmholtzMunich reveals how two molecular players, LUBAC and TRAF6, work together to fine-tune immune signaling in #Tcells.
👉 t1p.de/ejpf7
A new study by researchers at #HelmholtzMunich reveals how two molecular players, LUBAC and TRAF6, work together to fine-tune immune signaling in #Tcells.
👉 t1p.de/ejpf7
November 17, 2025 at 9:50 AM
Fine-Tuning #Immunity: The Role of #Ubiquitination in T cell Activation 🔬
A new study by researchers at #HelmholtzMunich reveals how two molecular players, LUBAC and TRAF6, work together to fine-tune immune signaling in #Tcells.
👉 t1p.de/ejpf7
A new study by researchers at #HelmholtzMunich reveals how two molecular players, LUBAC and TRAF6, work together to fine-tune immune signaling in #Tcells.
👉 t1p.de/ejpf7
One-Hour Glucose Level: A New Way to Prevent Type 2 Diabetes 🩸
A single blood glucose measurement one hour after an oral glucose tolerance test can reveal diabetes risk even before prediabetes develops, as researchers from #HelmholtzMunich, the University of Tübingen & the DZD show.
👉 t1p.de/dq0ia
A single blood glucose measurement one hour after an oral glucose tolerance test can reveal diabetes risk even before prediabetes develops, as researchers from #HelmholtzMunich, the University of Tübingen & the DZD show.
👉 t1p.de/dq0ia
November 14, 2025 at 11:07 AM
One-Hour Glucose Level: A New Way to Prevent Type 2 Diabetes 🩸
A single blood glucose measurement one hour after an oral glucose tolerance test can reveal diabetes risk even before prediabetes develops, as researchers from #HelmholtzMunich, the University of Tübingen & the DZD show.
👉 t1p.de/dq0ia
A single blood glucose measurement one hour after an oral glucose tolerance test can reveal diabetes risk even before prediabetes develops, as researchers from #HelmholtzMunich, the University of Tübingen & the DZD show.
👉 t1p.de/dq0ia
#WorldDiabetesDay
#WeFightDiabetes
At #HelmholtzMunich, researchers from different scientific backgrounds are closely connected to find new innovative approaches to prevent, treat & ultimately cure #diabetes & #obesity.
👉Discover more: t1p.de/16rz8
@helmholtz.de @diabresearch-dzd.bsky.social
#WeFightDiabetes
At #HelmholtzMunich, researchers from different scientific backgrounds are closely connected to find new innovative approaches to prevent, treat & ultimately cure #diabetes & #obesity.
👉Discover more: t1p.de/16rz8
@helmholtz.de @diabresearch-dzd.bsky.social
November 14, 2025 at 8:37 AM
#WorldDiabetesDay
#WeFightDiabetes
At #HelmholtzMunich, researchers from different scientific backgrounds are closely connected to find new innovative approaches to prevent, treat & ultimately cure #diabetes & #obesity.
👉Discover more: t1p.de/16rz8
@helmholtz.de @diabresearch-dzd.bsky.social
#WeFightDiabetes
At #HelmholtzMunich, researchers from different scientific backgrounds are closely connected to find new innovative approaches to prevent, treat & ultimately cure #diabetes & #obesity.
👉Discover more: t1p.de/16rz8
@helmholtz.de @diabresearch-dzd.bsky.social
👏 Congratulations to our Highly Cited Researchers!
▪️Prof. Marcus Conrad
▪️Prof. Matthias Blüher
▪️Prof. Fabian Theis
▪️Dr. Bettina Proneth
▪️Dr. Sebastian Doll
🎓 This distinction honors scientists whose publications rank among the most frequently cited worldwide.
▪️Prof. Marcus Conrad
▪️Prof. Matthias Blüher
▪️Prof. Fabian Theis
▪️Dr. Bettina Proneth
▪️Dr. Sebastian Doll
🎓 This distinction honors scientists whose publications rank among the most frequently cited worldwide.
November 13, 2025 at 11:21 AM
👏 Congratulations to our Highly Cited Researchers!
▪️Prof. Marcus Conrad
▪️Prof. Matthias Blüher
▪️Prof. Fabian Theis
▪️Dr. Bettina Proneth
▪️Dr. Sebastian Doll
🎓 This distinction honors scientists whose publications rank among the most frequently cited worldwide.
▪️Prof. Marcus Conrad
▪️Prof. Matthias Blüher
▪️Prof. Fabian Theis
▪️Dr. Bettina Proneth
▪️Dr. Sebastian Doll
🎓 This distinction honors scientists whose publications rank among the most frequently cited worldwide.
Primary Oral Insulin Trial (POInT)
First Results Imply Personalized Strategies for the Future of Type 1 Diabetes
👉 Learn more: t1p.de/x3pq6
🔗 To the original publication: t1p.de/4x9qu
@tum.de @diabresearch-dzd.bsky.social
#typ1diabetes #prevention #GPPAD #OralInsulin #Insulin
First Results Imply Personalized Strategies for the Future of Type 1 Diabetes
👉 Learn more: t1p.de/x3pq6
🔗 To the original publication: t1p.de/4x9qu
@tum.de @diabresearch-dzd.bsky.social
#typ1diabetes #prevention #GPPAD #OralInsulin #Insulin
November 12, 2025 at 8:42 AM
Primary Oral Insulin Trial (POInT)
First Results Imply Personalized Strategies for the Future of Type 1 Diabetes
👉 Learn more: t1p.de/x3pq6
🔗 To the original publication: t1p.de/4x9qu
@tum.de @diabresearch-dzd.bsky.social
#typ1diabetes #prevention #GPPAD #OralInsulin #Insulin
First Results Imply Personalized Strategies for the Future of Type 1 Diabetes
👉 Learn more: t1p.de/x3pq6
🔗 To the original publication: t1p.de/4x9qu
@tum.de @diabresearch-dzd.bsky.social
#typ1diabetes #prevention #GPPAD #OralInsulin #Insulin
TITAN: A Multimodal AI Model for Digital Pathology Slides
Researchers at #HelmholtzMunich, in collaboration with Harvard Medical School & international partners, have developed #TITAN – a multimodal #AI model that analyzes and describes digital #pathology slides.
👉 t1p.de/sz1wt
#FoundationModel
Researchers at #HelmholtzMunich, in collaboration with Harvard Medical School & international partners, have developed #TITAN – a multimodal #AI model that analyzes and describes digital #pathology slides.
👉 t1p.de/sz1wt
#FoundationModel
November 11, 2025 at 12:17 PM
TITAN: A Multimodal AI Model for Digital Pathology Slides
Researchers at #HelmholtzMunich, in collaboration with Harvard Medical School & international partners, have developed #TITAN – a multimodal #AI model that analyzes and describes digital #pathology slides.
👉 t1p.de/sz1wt
#FoundationModel
Researchers at #HelmholtzMunich, in collaboration with Harvard Medical School & international partners, have developed #TITAN – a multimodal #AI model that analyzes and describes digital #pathology slides.
👉 t1p.de/sz1wt
#FoundationModel
Biomolecular Breathing and the 4D View of Life
How do biomolecules breathe? This question was at the heart of the international #BNMRZ symposium, hosted by the Bavarian NMR Center – a joint infrastructure of #HelmholtzMunich and the @tum.de.
👉 Read more: t1p.de/dpfr7
#StructuralBiology #NMR #AI
How do biomolecules breathe? This question was at the heart of the international #BNMRZ symposium, hosted by the Bavarian NMR Center – a joint infrastructure of #HelmholtzMunich and the @tum.de.
👉 Read more: t1p.de/dpfr7
#StructuralBiology #NMR #AI
November 10, 2025 at 10:08 AM
Biomolecular Breathing and the 4D View of Life
How do biomolecules breathe? This question was at the heart of the international #BNMRZ symposium, hosted by the Bavarian NMR Center – a joint infrastructure of #HelmholtzMunich and the @tum.de.
👉 Read more: t1p.de/dpfr7
#StructuralBiology #NMR #AI
How do biomolecules breathe? This question was at the heart of the international #BNMRZ symposium, hosted by the Bavarian NMR Center – a joint infrastructure of #HelmholtzMunich and the @tum.de.
👉 Read more: t1p.de/dpfr7
#StructuralBiology #NMR #AI
🫁 How do lung cells react to nanoparticles within minutes?
Researchers at #HelmholtzMunich reveal how alveolar macrophages drive this rapid immune defense – shaping inflammation and protection in the lungs.
👉Read more: t1p.de/s5sba
#LungHealth #Immunology #Nanoparticles #LHI
Researchers at #HelmholtzMunich reveal how alveolar macrophages drive this rapid immune defense – shaping inflammation and protection in the lungs.
👉Read more: t1p.de/s5sba
#LungHealth #Immunology #Nanoparticles #LHI
November 10, 2025 at 7:09 AM
🫁 How do lung cells react to nanoparticles within minutes?
Researchers at #HelmholtzMunich reveal how alveolar macrophages drive this rapid immune defense – shaping inflammation and protection in the lungs.
👉Read more: t1p.de/s5sba
#LungHealth #Immunology #Nanoparticles #LHI
Researchers at #HelmholtzMunich reveal how alveolar macrophages drive this rapid immune defense – shaping inflammation and protection in the lungs.
👉Read more: t1p.de/s5sba
#LungHealth #Immunology #Nanoparticles #LHI
Maternal Type 1 #Diabetes May Protect Children Through #Epigenetic Changes
A study from #HelmholtzMunich, #GPPAD & the TU Dresden University of Technology reveals that specific epigenetic modifications in the child’s DNA may underlie this protective effect.
👉 t1p.de/2emq1
@tudresden.bsky.social
A study from #HelmholtzMunich, #GPPAD & the TU Dresden University of Technology reveals that specific epigenetic modifications in the child’s DNA may underlie this protective effect.
👉 t1p.de/2emq1
@tudresden.bsky.social
November 6, 2025 at 10:29 AM
Maternal Type 1 #Diabetes May Protect Children Through #Epigenetic Changes
A study from #HelmholtzMunich, #GPPAD & the TU Dresden University of Technology reveals that specific epigenetic modifications in the child’s DNA may underlie this protective effect.
👉 t1p.de/2emq1
@tudresden.bsky.social
A study from #HelmholtzMunich, #GPPAD & the TU Dresden University of Technology reveals that specific epigenetic modifications in the child’s DNA may underlie this protective effect.
👉 t1p.de/2emq1
@tudresden.bsky.social
#BNMRZ Symposium 2025
Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies
💻 Online attendance is still possible: t1p.de/zdr8j
👉 Further information: t1p.de/rjuz4
@tum.de
#StructuralBiology #CryoEM #AI #TherapeuticInnovations
Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies
💻 Online attendance is still possible: t1p.de/zdr8j
👉 Further information: t1p.de/rjuz4
@tum.de
#StructuralBiology #CryoEM #AI #TherapeuticInnovations
November 6, 2025 at 9:19 AM
#BNMRZ Symposium 2025
Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies
💻 Online attendance is still possible: t1p.de/zdr8j
👉 Further information: t1p.de/rjuz4
@tum.de
#StructuralBiology #CryoEM #AI #TherapeuticInnovations
Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies
💻 Online attendance is still possible: t1p.de/zdr8j
👉 Further information: t1p.de/rjuz4
@tum.de
#StructuralBiology #CryoEM #AI #TherapeuticInnovations
New Switch for Natural Cell Death🧬
Programmed cell death (#apoptosis) protects us, but cancer cells can evade it. Researchers at #HelmholtzMunich & TUM discovered a new molecular switch controlling this process.
👉 t1p.de/3fxvc
@tum.de @natureportfolio.nature.com
#CellDeath #BNMRZ
Programmed cell death (#apoptosis) protects us, but cancer cells can evade it. Researchers at #HelmholtzMunich & TUM discovered a new molecular switch controlling this process.
👉 t1p.de/3fxvc
@tum.de @natureportfolio.nature.com
#CellDeath #BNMRZ
November 4, 2025 at 10:12 AM
New Switch for Natural Cell Death🧬
Programmed cell death (#apoptosis) protects us, but cancer cells can evade it. Researchers at #HelmholtzMunich & TUM discovered a new molecular switch controlling this process.
👉 t1p.de/3fxvc
@tum.de @natureportfolio.nature.com
#CellDeath #BNMRZ
Programmed cell death (#apoptosis) protects us, but cancer cells can evade it. Researchers at #HelmholtzMunich & TUM discovered a new molecular switch controlling this process.
👉 t1p.de/3fxvc
@tum.de @natureportfolio.nature.com
#CellDeath #BNMRZ
Comparing Pancreas Development Across Species to Advance Diabetes Research
New insights from international researchers led by #HelmholtzMunich & #DZD could reshape the future of #diabetes modeling & #RegenerativeMedicine.
👉 t1p.de/zg0ra
@diabresearch-dzd.bsky.social @heikolickert.bsky.social
New insights from international researchers led by #HelmholtzMunich & #DZD could reshape the future of #diabetes modeling & #RegenerativeMedicine.
👉 t1p.de/zg0ra
@diabresearch-dzd.bsky.social @heikolickert.bsky.social
November 3, 2025 at 2:22 PM
Comparing Pancreas Development Across Species to Advance Diabetes Research
New insights from international researchers led by #HelmholtzMunich & #DZD could reshape the future of #diabetes modeling & #RegenerativeMedicine.
👉 t1p.de/zg0ra
@diabresearch-dzd.bsky.social @heikolickert.bsky.social
New insights from international researchers led by #HelmholtzMunich & #DZD could reshape the future of #diabetes modeling & #RegenerativeMedicine.
👉 t1p.de/zg0ra
@diabresearch-dzd.bsky.social @heikolickert.bsky.social
New Foundation Model Reveals How Cells Are Organized in Tissues
Researchers at #HelmholtzMunich & @tum.de have developed #Nicheformer, the first large-scale foundation model that integrates single-cell analysis with spatial transcriptomics.
👉 t1p.de/pxzwg
Researchers at #HelmholtzMunich & @tum.de have developed #Nicheformer, the first large-scale foundation model that integrates single-cell analysis with spatial transcriptomics.
👉 t1p.de/pxzwg
October 30, 2025 at 10:09 AM
New Foundation Model Reveals How Cells Are Organized in Tissues
Researchers at #HelmholtzMunich & @tum.de have developed #Nicheformer, the first large-scale foundation model that integrates single-cell analysis with spatial transcriptomics.
👉 t1p.de/pxzwg
Researchers at #HelmholtzMunich & @tum.de have developed #Nicheformer, the first large-scale foundation model that integrates single-cell analysis with spatial transcriptomics.
👉 t1p.de/pxzwg
PURA Syndrome Deutschland Supports Research at Helmholtz Munich
👉 t1p.de/jdvhp
💙 PURA Syndrome Deutschland e.V. has donated 10,000 Euros to Prof. Dierk Niessing’s research group at the Institute of Structural Biology at #HelmholtzMunich.
👉 t1p.de/jdvhp
💙 PURA Syndrome Deutschland e.V. has donated 10,000 Euros to Prof. Dierk Niessing’s research group at the Institute of Structural Biology at #HelmholtzMunich.
October 30, 2025 at 8:00 AM
PURA Syndrome Deutschland Supports Research at Helmholtz Munich
👉 t1p.de/jdvhp
💙 PURA Syndrome Deutschland e.V. has donated 10,000 Euros to Prof. Dierk Niessing’s research group at the Institute of Structural Biology at #HelmholtzMunich.
👉 t1p.de/jdvhp
💙 PURA Syndrome Deutschland e.V. has donated 10,000 Euros to Prof. Dierk Niessing’s research group at the Institute of Structural Biology at #HelmholtzMunich.
Decoding #Oat Diversity for a #Climate-Resilient Future🌾
This study provides valuable insights into how oats adapt to their environments – paving the way for more robust, climate-smart crops.
👉 t1p.de/gmmgb
@leibniz-gemeinschaft.de @natureportfolio.nature.com @tum.de
This study provides valuable insights into how oats adapt to their environments – paving the way for more robust, climate-smart crops.
👉 t1p.de/gmmgb
@leibniz-gemeinschaft.de @natureportfolio.nature.com @tum.de
October 29, 2025 at 5:27 PM
Decoding #Oat Diversity for a #Climate-Resilient Future🌾
This study provides valuable insights into how oats adapt to their environments – paving the way for more robust, climate-smart crops.
👉 t1p.de/gmmgb
@leibniz-gemeinschaft.de @natureportfolio.nature.com @tum.de
This study provides valuable insights into how oats adapt to their environments – paving the way for more robust, climate-smart crops.
👉 t1p.de/gmmgb
@leibniz-gemeinschaft.de @natureportfolio.nature.com @tum.de
🎖️ Prof. Ulrike Protzer receives the “Bundesverdienstkreuz” (Federal Cross of Merit) in recognition of her outstanding contributions to the field of virology.
👉 Read more in our news: t1p.de/gkjvc
@ulrike-protzer.bsky.social @tum.de
#Virology #TherVacB #HepatitisB
👉 Read more in our news: t1p.de/gkjvc
@ulrike-protzer.bsky.social @tum.de
#Virology #TherVacB #HepatitisB
October 29, 2025 at 10:32 AM
🎖️ Prof. Ulrike Protzer receives the “Bundesverdienstkreuz” (Federal Cross of Merit) in recognition of her outstanding contributions to the field of virology.
👉 Read more in our news: t1p.de/gkjvc
@ulrike-protzer.bsky.social @tum.de
#Virology #TherVacB #HepatitisB
👉 Read more in our news: t1p.de/gkjvc
@ulrike-protzer.bsky.social @tum.de
#Virology #TherVacB #HepatitisB
✨ Prof. Eric Topol visited #HelmholtzMunich for a roundtable on the future of #AI in healthcare. The discussion focused on the concept of the #VirtualHuman.
👉Read more: t1p.de/5wthc
#AIinMedicine #DigitalHuman #PrecisionMedicine
👉Read more: t1p.de/5wthc
#AIinMedicine #DigitalHuman #PrecisionMedicine
October 28, 2025 at 6:43 AM
✨ Prof. Eric Topol visited #HelmholtzMunich for a roundtable on the future of #AI in healthcare. The discussion focused on the concept of the #VirtualHuman.
👉Read more: t1p.de/5wthc
#AIinMedicine #DigitalHuman #PrecisionMedicine
👉Read more: t1p.de/5wthc
#AIinMedicine #DigitalHuman #PrecisionMedicine
Genetic Links Between Type 2 Diabetes and Multiple Health Conditions 🧬
A study led by Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at #HelmholtzMunich, investigates how genetic risk for type 2 diabetes can influence a wide range of health conditions.
👉 t1p.de/yq19p
A study led by Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at #HelmholtzMunich, investigates how genetic risk for type 2 diabetes can influence a wide range of health conditions.
👉 t1p.de/yq19p
October 22, 2025 at 12:18 PM
Genetic Links Between Type 2 Diabetes and Multiple Health Conditions 🧬
A study led by Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at #HelmholtzMunich, investigates how genetic risk for type 2 diabetes can influence a wide range of health conditions.
👉 t1p.de/yq19p
A study led by Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at #HelmholtzMunich, investigates how genetic risk for type 2 diabetes can influence a wide range of health conditions.
👉 t1p.de/yq19p
Helmholtz Munich at #ICCV2025 🤖
🌺 Our researchers from @comphealthmunich.bsky.social present cutting-edge #AI & #ComputerVision work in Hawaii.
👉 Explore their papers & more: t1p.de/8jfgn
#MachineLearning #ICCV #HelmholtzMunich
🌺 Our researchers from @comphealthmunich.bsky.social present cutting-edge #AI & #ComputerVision work in Hawaii.
👉 Explore their papers & more: t1p.de/8jfgn
#MachineLearning #ICCV #HelmholtzMunich
October 20, 2025 at 12:26 PM
Helmholtz Munich at #ICCV2025 🤖
🌺 Our researchers from @comphealthmunich.bsky.social present cutting-edge #AI & #ComputerVision work in Hawaii.
👉 Explore their papers & more: t1p.de/8jfgn
#MachineLearning #ICCV #HelmholtzMunich
🌺 Our researchers from @comphealthmunich.bsky.social present cutting-edge #AI & #ComputerVision work in Hawaii.
👉 Explore their papers & more: t1p.de/8jfgn
#MachineLearning #ICCV #HelmholtzMunich
Starker Andrang bei der FORSCHA 2025 🚀
#HelmholtzMunich war vertreten & zeigte gemeinsam mit unterschiedlichen Instituten und Einrichtungen ein vielfältiges, interaktives Programm.
👉Mehr dazu: t1p.de/8jfjd
@munichimaging.bsky.social
#HelmholtzMunich war vertreten & zeigte gemeinsam mit unterschiedlichen Instituten und Einrichtungen ein vielfältiges, interaktives Programm.
👉Mehr dazu: t1p.de/8jfjd
@munichimaging.bsky.social
October 17, 2025 at 7:55 AM
Starker Andrang bei der FORSCHA 2025 🚀
#HelmholtzMunich war vertreten & zeigte gemeinsam mit unterschiedlichen Instituten und Einrichtungen ein vielfältiges, interaktives Programm.
👉Mehr dazu: t1p.de/8jfjd
@munichimaging.bsky.social
#HelmholtzMunich war vertreten & zeigte gemeinsam mit unterschiedlichen Instituten und Einrichtungen ein vielfältiges, interaktives Programm.
👉Mehr dazu: t1p.de/8jfjd
@munichimaging.bsky.social